CompanyVNDANasdaqWashington, DC

Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals develops therapies across multiple therapeutic areas to address unmet medical needs.

SEC EDGAR ClinicalTrials.gov vandapharma.com

424B3Sep 11Latest SEC filing

Aug 5Latest story

August 2026

Vanda reports Q2 2026 results, reaffirms guidance and three Phase III readouts by year-end

Aug 5Quarterly updateiloperidone milsaperidone

July 2026

Vanda's HETLIOZ gets manufacturing supplement approval from FDA

Jul 27Regulatory decisiontasimelteon Vanda Pharmaceuticals Inc.